Journal of Rehabilitation Medicine 51-6 | страница 61

Chronic pain in ICU survivors
a high risk of developing chronic pain. This study did
not have a pre-defined sample size and was a sample of
convenience, thus may not have detected relationships
between variables.
In conclusion, the findings of this small-scale quality
improvement project suggest that post-ICU follow-up
programmes should provide the appropriate support
to manage chronic pain issues. Future large-scale,
multi-site research related to post-ICU chronic pain is
required to understand this problem further and to help
design appropriate, effective interventions for patients.
ACKNOWLEDGEMENTS
This work was supported by a Health Foundation Shine Award
(2014). The Health Foundation is a charitable organization.
Joanne McPeake was supported by a Chief Nursing Officer
(Scotland) Fellowship for the duration of this study. Joanne
McPeake and Tara Quasim are supported by grants from the
Society of Critical Care Medicine.
The authors have no conflicts of interest to declare.
discharge: an exploratory evaluation. J Crit Care 2016;
35: 180–184.
11. McPeake JM, Shaw M, Iwashyna TJ, Daniel M, Devine H,
Jarvie L, et al. Intensive Care Syndrome: Promoting In-
dependence and Return to Employment (InS:PIRE). Early
evaluation of a complex intervention. PLoS One 2017;
12: e0188028.
12. McPeake JM, Iwashyna TJ, Devine H, MacTavish P, Qua-
sim T, et al. Peer support to improve recovery following
critical care discharge: a case based discussion. Thorax
2017; 72: 856–858.
13. Scottish Government. Scottish Index of Multiple Depriva-
tion. A National Statistics Publication for Scotland. Edin-
burgh: Scottish Government; 2012.
14. Cleeland, CS. The Brief Pain Inventory user guide. 2009.
[accessed 2017 Jan 21]. Available from: https://www.
mdanderson.org/documents/Departments-and-Divisions/
Symptom-Research/BPI_UserGuide.pdf.
15. Arnold LM, Goldenberg DL, Stanford SB, Ladone JK,
Sandhu HS, Keck PE Jr, et al. Gabapentin in the treatment
of fibromyalgia – a randomized, double-blind, placebo-
controlled, multicenter trial. Arthritis Rheum 2007; 56,
1336–1344.
16. Breuer B, Pappagallo M, Knotkova H, Guleyupoqlu N,
Wallenstein S, Portenoy RK. A randomized, double-blind,
placebo-controlled, two-period, crossover, pilot trial of
lamotrigine in patients with central pain due to multiple
sclerosis. Clin Ther 2007; 29: 2022–2030.
17. Zalon ML. Comparison of pain measures in surgical pa-
tients. J Nurs Meas 1999; 7: 135–152.
18. Turk DC, Dworkin RH, Allen RR, Bellamy N, Brandenburg
N, Carr DB, et al. Core outcome domains for chronic pain
clinical trials: IMMPACT recommendations. Pain 2013;
106: 337–345.
19. Tan G, Jensen M, Thornby J, Shanti BF. Validation of the
Brief Pain Inventory for chronic non-malignant pain. J Pain
2004; 5: 133–137.
20. Jelsness-Jørgensen L, Moum B, Grimstad T, Jahnsen J,
Opheim R, Berset IP, et al. Validity, reliability, and re-
sponsiveness of the Brief Pain Inventory in inflammatory
bowel disease. Can J Gastroenterol Hepatol 2016; 2016:
5624261.
21. Kapstad H, Hanestad BR, Langeland N, Rustøen T, Stavem
K. Cutpoints for mild, moderate and severe pain in patients
with osteoarthritis of the hip or knee ready for joint repla-
cement surgery. BMC Musculoskeletal Disord 2008; 9: 55.
22. World Health Organization. Cancer pain relief. Geneva:
WHO; 1986.
23. Minitab 17.3.1 statistical software. 2016. State College,
PA: Minitab, Inc. Available from: www.minitab.com.
24. Dellinger R, Levy M, Rhodes A, Annane D, Gerlach H, Opal
SM, et al. Surviving sepsis campaign: international guidelines
for management of severe sepsis and septic shock: 2012.
Crit Care Med 2013; 41: 580–637.
25. Jacodic HK, Jacodic K, Podbregar M. Long term outcome
and quality of life of patients treated in a surgical intensive
care: a comparison between sepsis and trauma. Crit Care
2006; 10: R134.
26. Breivik H, Collett B, Ventafridda V, Cohen R, Gallacher D.
Survey of chronic pain in Europe: prevalence, impact on
daily life and treatment. Eur J Pain 2006; 10: 287–333.
27. Stollings JL, Bloom SL, Wang L, Ely EW, Jackson JC, Sevin
CM. Critical care pharmacists and medication management
in an ICU recovery center. Ann Pharmacother 2018; 52:
712–723.
REFERENCES
1. Iwashyna TJ. Survivorship will be the defining challenge
of critical care in the 21st century. Ann Intern Med 2010;
153: 204–205.
2. Needham DM, Davidson J, Cohen H, Hopkins RO, Weinert
R, Wunsch H, et al Improving long term outcomes after
discharge from intensive care unit: report from a stake-
holders conference. Crit Care Med 2012; 40: 502–509.
3. 3.Griffiths J, Hatch RA, Bishop J, Morgan K, Jenkinson C,
Cuthbertson BH, et al. An exploration of social and econo-
mic outcome and associated health-related quality of life
after critical illness in general intensive care unit survivors:
a 12-month follow-up study. Crit Care 2013; 17: R100.
4. Wade DM, Howell DC, Weinman JA, Hardy RJ, Mythen MG,
Brewin CR, et al. Investigating risk factors for psychological
morbidity three months after intensive care: a prospective
study. Crit Care 2012; 16: R192.
5. Herridge MS, Tansey CM, Matte A, Tomlinson G, Diaz-
Granados N, Cooper A, et al. Functional disability five
years after ARDS. N Engl J Med 2011; 364: 1293–304.
6. Elliott D, Davidson JE, Harvey MA, Bemis-Dougherty A,
Iwashyna TJ, Wagner J, et al Exploring the scope of post
intensive care syndrome therapy and care: engagement of
non-critical care providers and survivors in a second sta-
keholders meeting. Crit Care Med 2014; 42: 2518–2526.
7. Kyranou M. and Puntillo K. The transition from acute to
chronic pain: might intensive care unit patients be at risk?
Ann Intensive Care 2012; 2: 36.
8. British Pain Society. What is pain? 2016. [Accessed 2017
Mar 9]. Available from: www.britishpainsociety.org.
9. Battle CE, Lovett S, Hutchings, H. Chronic pain in survivors
of critical illness: a retrospective analysis of incidence and
risk factors. Crit Care 2013; 17: R101.
10. McPeake JM, Devine H, MacTavish P, Fleming L, Crawford
R, Struthers R, et al Caregiver strain following critical care
455
J Rehabil Med 51, 2019